Identification of structurally diverse Tau-Targeting PROTACs using Integrated Computational Prioritization framework
Abstract Tau-targeting proteolysis-targeting chimeras (PROTACs) offer a strategy for eliminating intracellular pathological Tau, but their development requires simultaneous optimization of central nervous system properties and ternary-complex formation. We developed an integrated computational framework for prioritizing Tau-targeting PROTACs from a 16,400-member combinatorial library comprising diverse Tau-binding ligands, linkers, cereblon (CRBN) recruiters, and exit vector variants. Candidates were evaluated using predicted stability and pharmacokinetic properties and ranked using a Brain-Targeted Multi-Parameter Optimization (BT-MPO) score. Benchmarking and weight-sensitivity analyses supported the robustness of compound ranking, while extended-connectivity fingerprint-based chemical-space analysis guided the selection of high-ranking candidates with broad structural representation. Ternary-complex modeling demonstrated that linker composition and conformational constraints influenced modeled Tau-PROTAC-CRBN assembly beyond linker length alone. Five leading candidates were subsequently examined using molecular-dynamics simulations, protein-ligand interaction analysis, relative MM/PBSA energetics, free-energy landscapes, and dynamic cross-correlation analysis. We identified a PROTAC candidate with the most favorable pharmacokinetic, and modeled ternary-complex stability profile. In summary, this study provides a systematic strategy for combining central nervous system (CNS)-oriented multiparameter prioritization with structural and dynamic analyses to identify diverse Tau-targeting PROTAC candidates for subsequent experimental evaluation.
Authors
- Banesh Sooram
- Lars O Tjernberg
- Lisha Wang
- Bengt Winblad
Institutions
- Karolinska Institutet (SE)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11427623/v1
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- preprint
Funders
- Gun och Bertil Stohnes Stiftelse
- Fondation pour la Recherche Médicale
- Hjärnfonden
- Karolinska Institutet
- Vetenskapsrådet
- Åhlén-stiftelsen